Close Menu

Companies like Genentech are hoping that personalized cancer vaccines take off, MIT's Technology Review reports.

It notes that the leadership there was initially skeptical that such a treatment could work, but in the years since, advances in genome sequencing as well as figuring out why the human immune system would target some cancer antigens but not other proteins, have helped them and others come around.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.

Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.

Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.

In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.